Mingxia Zhu

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

A nomogram integrating machine learning-derived CT radiomics and clinical characteristics for prognostic assessment in patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy with or without immunotherapy.

A nomogram integrating machine learning-derived CT radiomics and clinical characteristics for prognostic assessment in patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy with or without immunotherapy.

Journal: Journal of translational medicine
Published: May 19, 2025

Global patterns and burden of soft tissue and extraosseous sarcomas: trends from 1990 to 2021.

Global patterns and burden of soft tissue and extraosseous sarcomas: trends from 1990 to 2021.

Journal: BMC cancer
Published: January 31, 2025

Revealing the cuproptosis-lncRNA nexus in gastric cancer: A multicohort observational study.

Revealing the cuproptosis-lncRNA nexus in gastric cancer: A multicohort observational study.

Journal: Medicine
Published: April 13, 2024

Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.

Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.

Journal: Life sciences
Published: January 31, 2024

Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer.

Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer.

Journal: Aging
Published: August 03, 2023

Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.

Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.

Journal: Aging
Published: June 27, 2023

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors.

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors.

Journal: International journal of general medicine
Published: September 09, 2022

Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.

Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.

Journal: BioMed research international
Published: May 07, 2022

Prognostic value and immunological role of FOXM1 in human solid tumors.

Prognostic value and immunological role of FOXM1 in human solid tumors.

Journal: Aging
Published: March 11, 2022

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.

Journal: Journal of Cancer
Published: June 12, 2018

Prognostic value of candidate microRNAs in gastric cancer: A validation study.

Prognostic value of candidate microRNAs in gastric cancer: A validation study.

Journal: Cancer biomarkers : section A of Disease markers
Published: December 17, 2016

A panel of microRNA signature in serum for colorectal cancer diagnosis.

A panel of microRNA signature in serum for colorectal cancer diagnosis.

Journal: Oncotarget
Published: September 23, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026